Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From StemBioSys Inc.
Regulating Cell Therapies: Conditional Approval Under Consideration In Congress; FDA Plans Public Hearing
Does FDA need a new pathway to consider advances in cellular therapy? Some in Congress think so. FDA is inviting stakeholders to weigh in this fall.
- Research, Analytical Equipment & Supplies
- Gene Therapy, Cell Therapy
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.